These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11859270

  • 1. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Med Sci Monit; 2002 Feb; 8(2):BR69-74. PubMed ID: 11859270
    [Abstract] [Full Text] [Related]

  • 2. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472
    [Abstract] [Full Text] [Related]

  • 3. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 20; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
    Gündüz F, Kuru O, Sentürk UK.
    Int J Sports Med; 2005 Nov 20; 26(9):710-3. PubMed ID: 16237614
    [Abstract] [Full Text] [Related]

  • 5. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Nov 20; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 6. Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats.
    Broulík PD, Tesar V, Zima T, Jirsa M.
    Physiol Res; 2001 Nov 20; 50(4):353-8. PubMed ID: 11551140
    [Abstract] [Full Text] [Related]

  • 7. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z.
    Am J Physiol Renal Physiol; 2005 Oct 20; 289(4):F880-90. PubMed ID: 15942045
    [Abstract] [Full Text] [Related]

  • 8. Effects of ACE inhibition and angiotensin II receptor blockade on glomerular basement membrane protein excretion and charge selectivity in type 2 diabetic patients.
    Deyneli O, Yavuz D, Velioglu A, Cacina H, Aksoy N, Haklar G, Taga Y, Akalin S.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun 20; 7(2):98-103. PubMed ID: 17083064
    [Abstract] [Full Text] [Related]

  • 9. Enalapril prevents fatty liver in nephrotic rats.
    Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F.
    J Nephrol; 2002 Jun 20; 15(4):358-67. PubMed ID: 12243364
    [Abstract] [Full Text] [Related]

  • 10. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
    Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W.
    Med Sci Monit; 2005 Apr 20; 11(4):PI31-7. PubMed ID: 15795705
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 12. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
    Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, Nakhoul N, Hoffman A, Abassi Z.
    Am J Physiol Renal Physiol; 2008 Mar 15; 294(3):F628-37. PubMed ID: 18094029
    [Abstract] [Full Text] [Related]

  • 13. Effect of dietary protein intake and angiotensin converting enzyme inhibition in Heymann nephritis.
    Kaysen GA, Davies RW, Hutchison FN.
    Kidney Int Suppl; 1989 Nov 15; 27():S154-62. PubMed ID: 2561514
    [Abstract] [Full Text] [Related]

  • 14. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar 15; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 15. [The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy].
    Zima T, Tesar V, Rychlík I, Nĕmecek K, Poledne R, Stejskalová A, Tĕmínová J, Stípek S, Merta M.
    Cas Lek Cesk; 1995 Oct 18; 134(20):658-60. PubMed ID: 7489582
    [Abstract] [Full Text] [Related]

  • 16. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
    Haas M, de Boer E, de Jong PE, Moolenaar F, Meijer DK, de Zeeuw D.
    Clin Sci (Lond); 2003 Jul 18; 105(1):51-7. PubMed ID: 12636872
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF, Milena FJ, Mora C, León C, Claverie F, Flores C, García J.
    Kidney Int Suppl; 2005 Dec 18; (99):S98-102. PubMed ID: 16336586
    [Abstract] [Full Text] [Related]

  • 18. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V, Wangensteen R, Sainz J, Duarte J, O'Valle F, Osuna A, Vargas F.
    Clin Sci (Lond); 2004 Mar 18; 106(3):251-9. PubMed ID: 14521506
    [Abstract] [Full Text] [Related]

  • 19. The effect of enalapril on skin flap viability is independent of angiotensin II AT1 receptors.
    Pazoki-Toroudi H, Ajami M, Habibey R, Hajiaboli E, Firooz A.
    Ann Plast Surg; 2009 Jun 18; 62(6):699-702. PubMed ID: 19461289
    [Abstract] [Full Text] [Related]

  • 20. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA, Davies RW.
    J Am Soc Nephrol; 1990 Nov 18; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.